Imaging Biomarkers of Neurodegeneration in Alzheimer’s Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism
Author(s) -
Agnès Benvenutto,
Bernard Giusiano,
Lejla Koric,
Claude Guériot,
Mira Didic,
Olivier Félician,
Maxime Guye,
Éric Guedj,
Mathieu Ceccaldi
Publication year - 2018
Publication title -
journal of alzheimer s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.677
H-Index - 139
eISSN - 1875-8908
pISSN - 1387-2877
DOI - 10.3233/jad-180292
Subject(s) - neurodegeneration , atrophy , posterior cortical atrophy , neuroscience , medicine , disease , positron emission tomography , pet imaging , neuroimaging , pathology , magnetic resonance imaging , dementia , psychology , radiology
Neurodegeneration biomarkers are routinely used in the diagnosis of Alzheimer's disease (AD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom